M. Barker, K. Greenwood, M. Jackson, and S. Crowe, Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis, Archives of Clinical Neuropsychology, vol.19, issue.3, pp.437-454, 2004.
DOI : 10.1016/S0887-6177(03)00096-9

A. Benton, Manuel pour l'application du test de rétention visuelle, Applications cliniques et expérimentales (in French) Centre de Psychologie appliquée, 1965.

E. Bierman, H. Comijs, C. Gundy, C. Sonnenberg, C. Jonker et al., The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?, International Journal of Geriatric Psychiatry, vol.67, issue.12, pp.1194-1200, 2007.
DOI : 10.1002/gps.1811

S. Buffett-jerrott and S. Stewart, Cognitive and Sedative Effects of Benzodiazepine Use, Current Pharmaceutical Design, vol.8, issue.1, pp.45-58, 2002.
DOI : 10.2174/1381612023396654

R. Cumming, Epidemiology of Medication-Related Falls and Fractures in the Elderly, Drugs & Aging, vol.12, issue.1, pp.43-53, 1998.
DOI : 10.2165/00002512-199812010-00005

H. Curran, Benzodiazepines, memory and mood: a review, Psychopharmacology, vol.18, issue.4, pp.1-8, 1991.
DOI : 10.1007/BF02316856

M. Dealberto, G. Mcavay, T. Seeman, and L. Berkman, PSYCHOTROPIC DRUG USE AND COGNITIVE DECLINE AMONG OLDER MEN AND WOMEN, International Journal of Geriatric Psychiatry, vol.12, issue.5, pp.567-574, 1997.
DOI : 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V

J. Fastbom, Y. Forsell, and B. Winblad, Benzodiazepines May Have Protective Effects Against Alzheimer Disease, Alzheimer Disease & Associated Disorders, vol.12, issue.1, pp.14-17, 1998.
DOI : 10.1097/00002093-199803000-00002

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

D. Food and . Administration, Prescribing of minor tranquilizaers, FDA Drug Bulletin pp, pp.2-3, 1980.

R. Führer and F. Rouillon, La version française de l'échelle CES-D (Center for Epidemiologic Studies Depression Scale), Psychiatre et Psychobiologie, vol.4, pp.163-166, 1989.

D. Galasko, R. Gould, I. Abramson, and D. Salmon, Measuring cognitive change in a cohort of patients with Alzheimer's disease, Stat Med, vol.19, pp.11-12, 2000.

H. Autorité and D. Santé, Modalités d'arrêt des benzodiazépines et médicaments apparentés chez le patient âgé, 2007.

B. Isaacs and A. Kennie, The Set Test as an Aid to the Detection of Dementia in Old People, The British Journal of Psychiatry, vol.123, issue.4, pp.467-470, 1973.
DOI : 10.1192/bjp.123.4.467

H. Jacqmin-gadda, C. Fabrigoule, D. Commenges, and J. Dartigues, A 5-Year Longitudinal Study of the Mini-Mental State Examination in Normal Aging, American Journal of Epidemiology, vol.145, issue.6, pp.498-506, 1997.
DOI : 10.1093/oxfordjournals.aje.a009137

R. Lagnaoui, M. Tournier, Y. Moride, C. Wolfson, T. Ducruet et al., The risk of cognitive impairment in older community-dwelling women after benzodiazepine use, Age and Ageing, vol.38, issue.2, pp.226-228, 2009.
DOI : 10.1093/ageing/afn277

N. Laird and J. Ware, Random-Effects Models for Longitudinal Data, Biometrics, vol.38, issue.4, pp.963-974, 1982.
DOI : 10.2307/2529876

N. Lechevallier, A. Fourrier, and C. Berr, [Benzodiazepine use in the elderly: the EVA Study]. Revue d'epidemiologie et de sante publique, pp.317-326, 2003.

S. Madhusoodanan and O. Bogunovic, Safety of benzodiazepines in the geriatric population, Expert Opinion on Drug Safety, vol.7, issue.3, pp.485-493, 2004.
DOI : 10.1176/appi.ps.55.3.233

K. Morgan, H. Dallosso, S. Ebrahim, A. T. Fentem, and P. , Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home, BMJ, vol.296, issue.6622, pp.601-602, 1988.
DOI : 10.1136/bmj.296.6622.601

Y. Moride and L. Abenhaim, Evidence of the depletion of susceptibles effect in nonexperimental pharmacoepidemiologic research, Journal of clinical epidemiology, vol.47, issue.7, pp.731-737, 1994.

M. Ohayon and M. Lader, Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom, The Journal of Clinical Psychiatry, vol.63, issue.9, pp.817-825, 2002.
DOI : 10.4088/JCP.v63n0912

H. Park, O. Connell, J. Thomson, and R. , A systematic review of cognitive decline in the general elderly population, International Journal of Geriatric Psychiatry, vol.51, issue.12, pp.1121-1134, 2003.
DOI : 10.1002/gps.1023

S. Paterniti, C. Dufouil, and A. Alperovitch, Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging Study, Journal of Clinical Psychopharmacology, vol.22, issue.3, pp.285-293, 2002.
DOI : 10.1097/00004714-200206000-00009

C. Proust-lima, H. Amieva, J. Dartigues, and H. Jacqmin-gadda, Sensitivity of Four Psychometric Tests to Measure Cognitive Changes in Brain Aging-Population-based Studies, American Journal of Epidemiology, vol.165, issue.3, pp.344-350, 2007.
DOI : 10.1093/aje/kwk017

URL : https://hal.archives-ouvertes.fr/inserm-00130046

C. Proust-lima, J. Dartigues, and H. Jacqmin-gadda, Misuse of the Linear Mixed Model When Evaluating Risk Factors of Cognitive Decline, American Journal of Epidemiology, vol.174, issue.9, 2011.
DOI : 10.1093/aje/kwr243

URL : https://hal.archives-ouvertes.fr/inserm-00621015

C. Proust, H. Jacqmin-gadda, J. Taylor, J. Ganiayre, and D. Commenges, A Nonlinear Model with Latent Process for Cognitive Evolution Using Multivariate Longitudinal Data, Biometrics, vol.16, issue.4, pp.1014-1024, 2006.
DOI : 10.1111/j.1541-0420.2006.00573.x

URL : https://hal.archives-ouvertes.fr/inserm-00130040

R. Reitan, VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE, Perceptual and Motor Skills, vol.19, issue.3, pp.271-276, 1958.
DOI : 10.2466/pms.1958.8.3.271

K. Ritchie, I. Carriere, A. De-mendonca, F. Portet, J. Dartigues et al., The neuroprotective effects of caffeine: A prospective population study (the Three City Study), Neurology, vol.69, issue.6, pp.536-545, 2007.
DOI : 10.1212/01.wnl.0000266670.35219.0c

URL : https://hal.archives-ouvertes.fr/inserm-00168786

S. Stewart, The effects of benzodiazepines on cognition, J Clin Psychiatry, vol.66, issue.2, pp.9-13, 2005.

3. The and . Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, issue.6, pp.316-325, 2003.

H. Verdoux, R. Lagnaoui, and B. Begaud, Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies, Psychological Medicine, vol.35, issue.3, pp.307-315, 2005.
DOI : 10.1017/S0033291704003897

J. Vidal, J. Lacombe, J. Dartigues, F. Pasquier, P. Robert et al., Evaluation of the Impact of Memantine Treatment Initiation on Psychotropics Use: A Study from the French National Health Care Database, Neuroepidemiology, vol.31, issue.3, pp.193-200, 2008.
DOI : 10.1159/000158226

C. Wu, S. Wang, I. Chang, and K. Lin, The Association Between Dementia and Long-Term Use of Benzodiazepine in the Elderly: Nested Case???Control Study Using Claims Data, The American Journal of Geriatric Psychiatry, vol.17, issue.7, pp.614-620, 2009.
DOI : 10.1097/JGP.0b013e3181a65210